Dai-Ichi Karkare Limited (DIKL) was set up in 1960 as a private limited company for the manufacture of speciality chemicals. The Company entered into technical collaboration with the ...
Healthcare & Pharmaceuticalscategory· February 28, 2025 EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy The European Union's health regulator on Friday ...
"The second place was 'Dad' and the third place was 'Mom.' Dai-Ichi Life Insurance, which conducted the survey, analyzed that 'children are watching closely how their parents work and do housework." ...
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...
On March 11, 2025, we remember the profound loss and resilience of the people of Japan following the Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster. Fourteen years later ...
Naruto games offer unique storytelling experiences beyond classic story arcs, blending original narratives with combat-focused gameplay. Series like Rise Of A Ninja and Ultimate Ninja Storm ...
(Bloomberg) -- Dai-ichi Life Holdings Inc. said a US subsidiary agreed to transfer insurance blocks totaling about $9.7 billion in policy reserves to a reinsurance firm to improve earnings.
Most of the world’s population are ordinary humans while only a small fraction of them acquired Majiks and became witches. Since only women have shown affinity to magic in the past, Ichi is a ...
Disclaimer: This article has been developed and funded by Daiichi Sankyo. Daiichi Sankyo has more than 120 years of experience and scientific expertise. In 2019, they entered the oncology market ...
Cambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results